XML 114 R93.htm IDEA: XBRL DOCUMENT v3.6.0.2
LEGAL PROCEEDINGS AND CONTINGENCIES (Details)
$ in Millions
12 Months Ended
Dec. 31, 2016
USD ($)
lawsuits
Anti-PD-1 Antibody Patent Litigation [Member]  
Legal Proceedings And Contingencies [Line Items]  
Litigation settlement, gross | $ $ 625.0
Royalty % to be received - 2017 - 2023 6.50%
Royalty % to be received - 2024 - 2026 2.50%
Percent BMS will keep after sharing with Ono 75.00%
Percentage BMS shares with Ono 25.00%
Plavix Product Liability [Member]  
Legal Proceedings And Contingencies [Line Items]  
Number of lawsuits 5,300
Byetta Product Liability Litigation [Member]  
Legal Proceedings And Contingencies [Line Items]  
Number of lawsuits 500
Number of current plaintiffs 2,000
Number of plaintiffs settled 30
Abilify Product Liability [Member]  
Legal Proceedings And Contingencies [Line Items]  
Number of lawsuits 130
Eliquis Product Liability [Member] | United States [Member]  
Legal Proceedings And Contingencies [Line Items]  
Number of lawsuits 80
Eliquis Product Liability [Member] | Canada [Member]  
Legal Proceedings And Contingencies [Line Items]  
Number of lawsuits 2
Shareholder Derivative Litigation [Member]  
Legal Proceedings And Contingencies [Line Items]  
Litigation settlement, gross | $ $ 14.7
Loss Contingency, Claims Dismissed, Number 2
Number of lawsuits 3
Abilify Government Investigation [Member]  
Legal Proceedings And Contingencies [Line Items]  
Number of states not participating in settlement 1
Cercla Matters [Member]  
Legal Proceedings And Contingencies [Line Items]  
Loss contingency, estimate of possible loss | $ $ 62.0